Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.

AUTOR(ES)

Wu, T C

RESUMO

The presentation of antigenic peptides by major histocompatibility complex (MHC) class II molecules to CD4+ T cells is critical to the function of the immune system. In this study, we have utilized the sorting signal of the lysosomal-associated membrane protein LAMP-1 to target a model antigen, human papillomavirus 16 E7 (HPV-16 E7), into the endosomal and lysosomal compartments. The LAMP-1 sorting signal reroutes the antigen into the MHC class II processing pathway, resulting in enhanced presentation to CD4+ cells in vitro. In vivo immunization experiments in mice demonstrated that vaccinia containing the chimeric E7/LAMP-1 gene generated greater E7-specific lymphoproliferative activity, antibody titers, and cytotoxic T-lymphocyte activities than vaccinia containing the wild-type HPV-16 E7 gene. These results suggest that specific targeting of an antigen to the endosomal and lysosomal compartments enhances MHC class II presentation and vaccine potency.

Documentos Relacionados

• Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules
• Murine epidermal Langerhans cells express significant amounts of class I major histocompatibility complex antigens.
• Inhibition of insulin receptor phosphorylation by peptides derived from major histocompatibility complex class I antigens.
• Isolation of carp genes encoding major histocompatibility complex antigens.
• Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation